To further study the mechanism underlying the protective effect of WBP2 on NAFLD, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to screen the interacting proteins. Here, WBP2 is linked to metabolic dysfunction-associated steatotic liver disease.